IC
PTCT icon

IEQ Capital’s PTC Therapeutics PTCT Stock Holding History

IEQ Capital’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
19,611
-2,710
-12% -$196K 0.01% 901
2026
Q1 		$1.52M Sell
22,321
-13,360
-37% -$946K 0.01% 876
2025
Q4 		$2.71M Buy
35,681
+3,348
+10% +$243K 0.01% 696
2025
Q3 		$1.98M Sell
32,333
-27,773
-46% -$1.45M 0.01% 769
2025
Q2 		$2.94M Buy
60,106
+16,211
+37% +$770K 0.02% 559
2025
Q1 		$2.24M Buy
43,895
+38,804
+762% +$1.94M 0.02% 558
2024
Q4 		$230K Buy
+5,091
New +$218K ﹤0.01% 1144

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

IEQ Capital's PTCT Position: Q2 2026 in Review

IEQ Capital reduced its PTC Therapeutics (PTCT) stake by 12% in Q2 2026, selling an estimated $196K and leaving 19,611 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #901.

IEQ Capital first reported a position in PTCT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.94M in Q2 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • IEQ Capital held 19,611 shares of PTC Therapeutics worth $1.6M as of Q2 2026.
  • IEQ Capital sold 2,710 PTC Therapeutics shares in Q2 2026, an estimated $196K.
  • PTC Therapeutics made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #901 holding.
  • IEQ Capital first reported a position in PTC Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • IEQ Capital's PTC Therapeutics position peaked at $2.94M in Q2 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.